GlobeNewswire Inc.··NaInventiva Bolsters Executive Team Ahead of Critical Lanifibranor Phase 3 Data
Inventiva appoints three new executives to strengthen leadership before anticipated Phase 3 lanifibranor trial results expected in Q4 2026.
IVAGeneral CounselPhase 3 trial